The DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.
Mutations in GNA11 in Uveal Melanoma
Open accessAbstract
BACKGROUND: Uveal melanoma is the most common intraocular cancer. There are no effective therapies for metastatic disease. Mutations in GNAQ, the gene encoding an alpha subunit of heterotrimeric G proteins, are found in 40% of uveal melanomas. METHODS: We sequenced exon 5 of GNAQ and GNA11, a paralogue of GNAQ, in 713 melanocytic neoplasms of different types (186 uveal melanomas, 139 blue nevi, 106 other nevi, and 282 other melanomas). We sequenced exon 4 of GNAQ and GNA11 in 453 of these samples and in all coding exons of GNAQ and GNA11 in 97 uveal melanomas and 45 blue nevi. RESULTS: We found somatic mutations in exon 5 (affecting Q209) and in exon 4 (affecting R183) in both GNA11 and GNAQ, in a mutually exclusive pattern. Mutations affecting Q209 in GNA11 were present in 7% of blue nevi, 32% of primary uveal melanomas, and 57% of uveal melanoma metastases. In contrast, we observed Q209 mutations in GNAQ in 55% of blue nevi, 45% of uveal melanomas, and 22% of uveal melanoma metastases. Mutations affecting R183 in either GNAQ or GNA11 were less prevalent (2% of blue nevi and 6% of uveal melanomas) than the Q209 mutations. Mutations in GNA11 induced spontaneously metastasizing tumors in a mouse model and activated the mitogen-activated protein kinase pathway. CONCLUSIONS: Of the uveal melanomas we analyzed, 83% had somatic mutations in GNAQ or GNA11. Constitutive activation of the pathway involving these two genes appears to be a major contributor to the development of uveal melanoma. (Funded by the National Institutes of Health and others.).
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Mutations of the BRAF gene in human cancer
Davies, H., Bignell, G. R., Cox, C., Stephens, P., Edkins, S., Clegg, S., Teague, J., Woffendin, H., Garnett, M. J., Bottomley, W., et al. (2002) · Nature · doi:10.1038/nature00766 · Cited by 10,674
High frequency of BRAF mutations in nevi
Pollock, P. M., Harper, U. L., Hansen, K. S., Yudt, L. M., Stark, M., Robbins, C. M., Moses, T. Y., Hostetter, G., Wagner, U., Kakareka, J., et al. (2003) · Nature Genetics · doi:10.1038/ng1054 · Cited by 1,730
A comprehensive catalogue of somatic mutations from a human cancer genome
Pleasance, E. D., Cheetham, R. K., Stephens, P. J., McBride, D. J., Humphray, S. J., Greenman, C. D., Varela, I., Lin, M.-L., Ordóñez, G. R., Bignell, G. R., et al. (2010) · Nature · doi:10.1038/nature08658 · Cited by 1,696
Frequent somatic mutations of GNAQ in uveal melanoma and blue naevi
Van Raamsdonk, C. D., Bezrookove, V., Green, G., Bauer, J., Gaugler, L., O’Brien, J. M., Simpson, E. M., Barsh, G. S., & Bastian, B. C. (2009) · Nature · doi:10.1038/nature07586 · Cited by 1,623
Self-citationLandis, C. A., Masters, S. B., Spada, A., Pace, A. M., Bourne, H. R., & Vallar, L. (1989) · Nature · doi:10.1038/340692a0 · Cited by 1,441
Neves, S. R., Ram, P. T., & Iyengar, R. (2002) · Science · doi:10.1126/science.1071550 · Cited by 1,286
Two G Protein Oncogenes in Human Endocrine Tumors
Lyons, J., Landis, C. A., Harsh, G., Vallar, L., Grünewald, K., Feichtinger, H., Duh, Q.-Y., Clark, O. H., Kawasaki, E., Bourne, H. R., et al. (1990) · Science · doi:10.1126/science.2116665 · Cited by 1,037
Mutations induced by ultraviolet light
Pfeifer, G. P., You, Y.-H., & Besaratinia, A. (2005) · Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis · doi:10.1016/j.mrfmmm.2004.06.057 · Cited by 775
Schwann Cell Precursors from Nerve Innervation Are a Cellular Origin of Melanocytes in Skin
Adameyko, I., Lallemend, F., Aquino, J. B., Pereira, J. A., Topilko, P., Müller, T., Fritz, N., Beljajeva, A., Mochii, M., Liste, I., et al. (2009) · Cell · doi:10.1016/j.cell.2009.07.049 · Cited by 590
GTPase mechanism of Gproteins from the 1.7-Å crystal structure of transducin α - GDP AIF−4
Sondek, J., Lambright, D. G., Noel, J. P., Hamm, H. E., & Sigler, P. B. (1994) · Nature · doi:10.1038/372276a0 · Cited by 558
Bennett, D. C., Cooper, P. J., & Hart, I. R. (1987) · International Journal of Cancer · doi:10.1002/ijc.2910390324 · Cited by 479
A Novel Gαq/11-selective Inhibitor
Takasaki, J., Saito, T., Taniguchi, M., Kawasaki, T., Moritani, Y., Hayashi, K., & Kobori, M. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m408846200 · Cited by 396
Oncogenic Mutations in GNAQ Occur Early in Uveal Melanoma
Onken, M. D., Worley, L. A., Long, M. D., Duan, S., Council, M. L., Bowcock, A. M., & Harbour, J. W. (2008) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.08-2145 · Cited by 346
Uveal Melanoma: Epidemiologic Aspects
SINGH, A., BERGMAN, L., & SEREGARD, S. (2005) · Ophthalmology Clinics of North America · doi:10.1016/j.ohc.2004.07.002 · Cited by 299
Lifetime prevalence of uveal melanoma in white patients with oculo(dermal) melanocytosis
Singh, A. D., De Potter, P., Fijal, B. A., Shields, C. L., Shields, J. A., & Elston, R. C. (1998) · Ophthalmology · doi:10.1016/s0161-6420(98)92205-9 · Cited by 275
Ultraviolet radiation and melanoma: a systematic review and analysis of reported sequence variants
Hocker, T., & Tsao, H. (2007) · Human Mutation · doi:10.1002/humu.20481 · Cited by 257
Embryonic cardiomyocyte hypoplasia and craniofacial defects in Galpha q/Galpha 11-mutant mice
Offermanns, S. (1998) · The EMBO Journal · doi:10.1093/emboj/17.15.4304 · Cited by 236
Zuidervaart, W., van Nieuwpoort, F., Stark, M., Dijkman, R., Packer, L., Borgstein, A.-M., Pavey, S., van der Velden, P., Out, C., Jager, M. J., et al. (2005) · British Journal of Cancer · doi:10.1038/sj.bjc.6602598 · Cited by 221
Effects of G-protein mutations on skin color
Van Raamsdonk, C. D., Fitch, K. R., Fuchs, H., de Angelis, M. H., & Barsh, G. S. (2004) · Nature Genetics · doi:10.1038/ng1412 · Cited by 183
Self-citationSeparate GTP Binding and GTPase Activating Domains of a Gα Subunit
Markby, D. W., Onrust, R., & Bourne, H. R. (1993) · Science · doi:10.1126/science.8266082 · Cited by 176
Sunlight exposure and pathogenesis of uveal melanoma
Singh, A. D., Rennie, I. G., Seregard, S., Giblin, M., & McKenzie, J. D. (2004) · Survey of Ophthalmology · doi:10.1016/j.survophthal.2004.04.009 · Cited by 163
Mutated alpha subunit of the Gq protein induces malignant transformation in NIH 3T3 cells.
Kalinec, G., Nazarali, A. J., Hermouet, S., Xu, N., & Gutkind, J. S. (1992) · Molecular and Cellular Biology · doi:10.1128/mcb.12.10.4687 · Cited by 161
Küsters‐Vandevelde, H. V. N., Klaasen, A., Küsters, B., Groenen, P. J. T. A., Grunsven, I. C. H. V. E.-V., van Dijk, M. R. C. F., Reifenberger, G., Wesseling, P., & Blokx, W. A. M. (2009) · Acta Neuropathologica · doi:10.1007/s00401-009-0611-3 · Cited by 154
Sun exposure predicts risk of ocular melanoma in Australia
Vajdic, C. M., Kricker, A., Giblin, M., McKenzie, J. D., Aitken, J. F., Giles, G. G., & Armstrong, B. K. (2002) · International Journal of Cancer · doi:10.1002/ijc.10579 · Cited by 152
Genetics of dark skin in micePreprint
Fitch, K. R., McGowan, K. A., van Raamsdonk, C. D., Fuchs, H., Lee, D., Puech, A., Hérault, Y., Threadgill, D. W., de Angelis, M. H., & Barsh, G. S. (2003) · Genes & Development · doi:10.1101/gad.1023703 · Cited by 146
High BRAF mutation frequency does not characterize all melanocytic tumor types
Saldanha, G. S., Purnell, D., Fletcher, A., Potter, L., Gillies, A., & Pringle, J. H. (2004) · International Journal of Cancer · doi:10.1002/ijc.20325 · Cited by 141
Oncogenic GNAQ mutations are not correlated with disease-free survival in uveal melanoma
Bauer, J. M., Kilic, E., Vaarwater, J., Bastian, B. C., Garbe, C., & de Klein, A. (2009) · British Journal of Cancer · doi:10.1038/sj.bjc.6605226 · Cited by 133
Self-citationPatterns of tumor initiation in choroidal melanoma.
Li, W., Judge, H., Gragoudas, E. S., Seddon, J. M., & Egan, K. M. (2000) · PubMed · Cited by 75
Mainster, M. A., & Turner, P. L. (2010) · American Journal of Ophthalmology · doi:10.1016/j.ajo.2009.11.028 · Cited by 45
Cited by
Hippo pathway in organ size control, tissue homeostasis, and cancer
Yu, F.-X., Zhao, B., & Guan, K.-L. (2015) · Cell · doi:10.1016/j.cell.2015.10.044 · Cited by 2,206
Regulation of the Hippo-YAP Pathway by G-Protein-Coupled Receptor Signaling
Yu, F.-X., Zhao, B., Panupinthu, N., Jewell, J. L., Lian, I., Wang, L. H., Zhao, J., Yuan, H., Tumaneng, K., Li, H., et al. (2012) · Cell · doi:10.1016/j.cell.2012.06.037 · Cited by 1,628
Schadendorf, D., van Akkooi, A. C. J., Berking, C., Griewank, K. G., Gutzmer, R., Hauschild, A., Stang, A., Roesch, A., & Ugurel, S. (2018) · The Lancet · doi:10.1016/s0140-6736(18)31559-9 · Cited by 1,488
Self-citationA compendium of mutational cancer driver genes
Martínez-Jiménez, F., Muiños, F., Sentís, I., Deu-Pons, J., Reyes-Salazar, I., Arnedo-Pac, C., Mularoni, L., Pich, O., Bonet, J., Kranas, H., et al. (2020) · Nature Reviews Cancer · doi:10.1038/s41568-020-0290-x · Cited by 1,296
The Hippo pathway: regulators and regulations.
Yu, F.-X., & Guan, K.-L. (2013) · Genes & Development · doi:10.1101/gad.210773.112 · Cited by 1,231
Metadata
- Authors
- Van Raamsdonk, C. D., Griewank, K. G., Crosby, M. B., Garrido, M. C., Vemula, S., Wiesner, T., Obenauf, A. C., Wackernagel, W., Green, G., Bouvier, N., Sozen, M. M., Baimukanova, G., Roy, R., Heguy, A., Dolgalev, I., Khanin, R., Busam, K., Speicher, M. R., O'Brien, J., & Bastian, B. C.
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2010-12-02
- Volume
- 363
- Issue
- 23
- Pages
- 2191-2199
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2077517114
- Cited by
- 1,476
- References
- 29
- FWCI
- 83.08
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.